Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:43 AM UTC
| NCT Number | NCT04546399 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 461 participants |
| Active Locations | 211 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 1, 2026 (Sep 1, 2026) |
As of October 15, 2026: Clinical trial NCT04546399 is currently recruiting participants. This phase2 study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 211 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04546399 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 211 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04546399 was last updated Sep 1, 2026 (September 1, 2026). HelloStudys verifies this status automatically.